The Angio-Seal Evolution device is designed to enable physicians to quickly and effectively seal femoral artery punctures made during minimally invasive catheter-based procedures. Effectively sealing the puncture helps achieve hemostasis quickly, enabling the patient to walk and resume activities sooner.
According to the company, the Angio-Seal evolution platform features an entirely new delivery system that significantly reduces the variability that can occur as physicians deploy and secure the Angio-Seal closure system.
Angio-Seal closure devices also increase hospital productivity and efficiency by reducing the length of patient stays in the catheterization lab or recovery area, thus providing potential cost savings, the company said.
Frank Callaghan, president of cardiovascular division at St Jude Medical, said: “We are confident the Evolution platform will further enhance Angio-Seal’s position as the recognized leader in vascular closure and provide physicians with increased confidence in the ease of device deployment and predictability.”